Editas Medicine (EDIT) Cash from Operations (2015 - 2025)
Editas Medicine (EDIT) reported Cash from Operations of 30843000.0 for Q3 2025, up 41.35% year-over-year from 21820344.72 in Q3 2024, and up 38.57% on a QoQ basis from 50212000.0 in Q2 2025.
Editas Medicine (EDIT) has 11 years of Cash from Operations data on file, last reported at 30843000.0 in Q3 2025.
- Quarterly Cash from Operations rose 41.35% year-over-year to 30843000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 179616000.0 (up 1.18% YoY) and the FY2024 annual result came in at 210284000.0, down 59.09% from the prior year.
- Cash from Operations improved to 30843000.0 in Q3 2025 per EDIT's latest filing, from 50212000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 22240000.0 in Q4 2023 and bottomed at 57062000.0 in Q2 2024.
- The 5-year median for Cash from Operations is 42273000.0 (2022), against an average of 42761473.68.
- The widest annual swing landed in 2023, when Cash from Operations surged 47.39%; it then tumbled 128.25% in 2024.
- Tracing EDIT's Cash from Operations over 5 years: stood at 34582000.0 in 2021, then slipped by 22.24% to 42273000.0 in 2022, then surged by 47.39% to 22240000.0 in 2023, then plunged by 128.25% to 50762000.0 in 2024, then jumped by 39.24% to 30843000.0 in 2025.
- Per Business Quant, the three latest EDIT Cash from Operations figures stand at 30843000.0 (Q3 2025), 50212000.0 (Q2 2025), and 47799000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30.84 Mn |
| Sep 30, 2025 | -30.84 Mn |
| Jun 30, 2025 | -50.21 Mn |
| Jun 30, 2025 | -50.21 Mn |
| Mar 31, 2025 | -47.80 Mn |
| Mar 31, 2025 | -47.80 Mn |
| Dec 31, 2024 | -50.76 Mn |
| Dec 31, 2024 | -50.76 Mn |
| Sep 30, 2024 | -52.59 Mn |
| Sep 30, 2024 | -52.59 Mn |
| Jun 30, 2024 | -57.06 Mn |
| Jun 30, 2024 | -57.06 Mn |
| Mar 31, 2024 | -49.87 Mn |
| Mar 31, 2024 | -49.87 Mn |
| Dec 31, 2023 | -22.24 Mn |
| Dec 31, 2023 | -22.24 Mn |
| Sep 30, 2023 | -35.46 Mn |
| Sep 30, 2023 | -35.46 Mn |
| Jun 30, 2023 | -38.71 Mn |
| Jun 30, 2023 | -38.71 Mn |
| Mar 31, 2023 | -35.77 Mn |
| Mar 31, 2023 | -35.77 Mn |
| Dec 31, 2022 | -42.27 Mn |
| Dec 31, 2022 | -42.27 Mn |
| Sep 30, 2022 | -48.00 Mn |
| Sep 30, 2022 | -48.00 Mn |
| Jun 30, 2022 | -37.85 Mn |
| Jun 30, 2022 | -37.85 Mn |
| Mar 31, 2022 | -49.23 Mn |
| Mar 31, 2022 | -49.23 Mn |
| Dec 31, 2021 | -34.58 Mn |
| Dec 31, 2021 | -34.58 Mn |
| Sep 30, 2021 | -40.79 Mn |
| Sep 30, 2021 | -40.79 Mn |
| Jun 30, 2021 | -38.96 Mn |
| Jun 30, 2021 | -38.96 Mn |
| Mar 31, 2021 | -49.48 Mn |
| Mar 31, 2021 | -49.48 Mn |
| Dec 31, 2020 | -40.10 Mn |
| Dec 31, 2020 | -40.10 Mn |
| Sep 30, 2020 | -54.80 Mn |
| Sep 30, 2020 | -54.80 Mn |
| Jun 30, 2020 | -30.86 Mn |
| Jun 30, 2020 | -30.86 Mn |
| Mar 31, 2020 | -54.09 Mn |
| Mar 31, 2020 | -54.09 Mn |
| Dec 31, 2019 | 41.02 Mn |
| Dec 31, 2019 | 41.02 Mn |
| Sep 30, 2019 | -26.88 Mn |
| Sep 30, 2019 | -26.88 Mn |
| Jun 30, 2019 | -25.81 Mn |
| Jun 30, 2019 | -25.81 Mn |
| Mar 31, 2019 | -29.00 Mn |
| Mar 31, 2019 | -29.00 Mn |
| Dec 31, 2018 | 1.33 Mn |
| Dec 31, 2018 | 1.33 Mn |
| Sep 30, 2018 | -7.84 Mn |
| Sep 30, 2018 | -7.84 Mn |
| Jun 30, 2018 | -16.73 Mn |
| Jun 30, 2018 | -16.73 Mn |
| Mar 31, 2018 | -22.46 Mn |
| Mar 31, 2018 | -22.46 Mn |
| Sep 30, 2017 | 15.65 Mn |
| Sep 30, 2017 | 15.65 Mn |
| Jun 30, 2017 | 43.63 Mn |
| Jun 30, 2017 | 43.63 Mn |
| Mar 31, 2017 | 69.79 Mn |
| Mar 31, 2017 | 69.79 Mn |
| Dec 31, 2016 | -13.68 Mn |
| Dec 31, 2016 | -13.68 Mn |
| Sep 30, 2016 | -17.04 Mn |
| Sep 30, 2016 | -17.04 Mn |
| Jun 30, 2016 | -9.90 Mn |
| Jun 30, 2016 | -9.90 Mn |
| Mar 31, 2016 | -9.63 Mn |
| Mar 31, 2016 | -9.63 Mn |
| Dec 31, 2015 | -8.01 Mn |
| Dec 31, 2015 | -8.01 Mn |
| Sep 30, 2015 | -11.94 Mn |
| Sep 30, 2015 | -11.94 Mn |
| Jun 30, 2015 | 20.45 Mn |
| Jun 30, 2015 | 20.45 Mn |
| Mar 31, 2015 | -5.94 Mn |
| Mar 31, 2015 | -5.94 Mn |